[1. Calonje E. Tumours of the skin appendages. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. 6th ed. Oxford: Blackwell Publishing; 2010. p. 53.1-53.44.10.1002/9781444317633.ch53]Search in Google Scholar
[2. Chen M, Liu H, Fu X, Yu Y, Yu G, Tian H, et al. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma and eccrine spiradenoma. Int J Dermatol 2013;52(12):1602-4.10.1111/j.1365-4632.2011.05329.x]Search in Google Scholar
[3. Hu G, Onder M, Gill M, Aksakal B, Oztas M, Gurer MA, et al. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome. J Invest Dermatol 2003;121:732–4.10.1046/j.1523-1747.2003.12514.x]Search in Google Scholar
[4. Bowen S, Gill M, Lee DA, Fisher G, Geronemus RG, Vazquez ME, et al. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation. J Invest Dermatol 2005;124:919–20.10.1111/j.0022-202X.2005.23688.x]Search in Google Scholar
[5. Dubois A, Wilson V, Bourn D, Rajan N. Genetic testing for Brooke-Spiegler syndrome, familial cylindromatosis and multiple familial trichoepitheliomas. PLoS Curr 2015;9(7).10.1371/currents.eogt.45c4e63dd43d62e12228cc5264d6a0db]Search in Google Scholar
[6. Rajan N, Langtry JA, Ashworth A, Roberts C, Chapman P, Burn J, et al. Tumor mapping in 2 large multigenerational families with CYLD mutations: Implications for disease management and tumor induction. Arch Dermatol 2009;145(11):1277-84.10.1001/archdermatol.2009.262]Search in Google Scholar
[7. Guardoli D, Argenziano G, Ponti G, Nasti S, Zalaudek I, Moscarella E, et al. A novel CYLD germline mutation in Brooke-Spiegler syndrome. J Eur Acad Dermatol Venereol 2015;29(3):457-62.10.1111/jdv.12578]Search in Google Scholar
[8. Shiver M, Hughes M, Naylor M, McLarney B, Stolle C, Shalin S, Gao L. A novel CYLD gene mutation and multiple basal cell carcinomas in a patient with Brooke-Spiegler syndrome. Clin Exp Dermatol 2015 May 15. doi: 10.1111/ced.12669.10.1111/ced.12669]Search in Google Scholar
[9. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003;424(6950):797–801.10.1038/nature01811]Search in Google Scholar
[10. Borik L, Heller P, Shrivastava M, Kazlouskaya V. Malignant cylindroma in a patient with Brooke-Spiegler syndrome. Dermatol Pract Concept 2015;5(2):61-5.10.5826/dpc.0502a09]Search in Google Scholar
[11. Clarke J, Ioffreda M, Helm KF. Multiple familial trichoepitheliomas: a folliculosebaceous-apocrine genodermatosis. Am J Dermatopathol 2002;24:402–5.10.1097/00000372-200210000-00005]Search in Google Scholar
[12. Rajan N, Elliott R, Clewes O, Mackay A, Reis-Filho JS, Burn J, et al. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours. Oncogene 2011;30(41):4243-60.10.1038/onc.2011.133]Search in Google Scholar
[13. Oosterkamp HM, Neering H, Nijman SM, Dirac AM, Mooi WJ, Bernards R, et al. An evaluation of the efficacy of topical application of salicylic acid for the treatment of familial cylindromatosis. Br J Dermatol 2006;155:182-5.10.1111/j.1365-2133.2006.07224.x]Search in Google Scholar
[14. Gerretsen AL, van der Putte SC, Deenstra W, van Vloten WA. Cutaneous cylindroma with malignant transformation. Cancer 1993;72(5):1618-23.10.1002/1097-0142(19930901)72:5<1618::AID-CNCR2820720521>3.0.CO;2-5]Search in Google Scholar
[15. Malzone MG, Campanile AC, Losito NS, Longo F, Perri F, Caponigro F, et al. Brooke-Spiegler syndrome presenting multiple concurrent cutaneous and parotid gland neoplasms: cytologic findings on fine-needle sample and description of a novel mutation of the CYLD gene. Diagn Cytopathol 2015;43(8):654-8.10.1002/dc.23275]Search in Google Scholar